Dabigatran etexilate Terminated Phase 2 Trials for thrombotic events / Bleeding Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02872649Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device (LVAD)